Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers
<p>Abstract</p> <p>This is an in-depth review of the history of quinacrine as well as its pharmacokinetic properties and established record of safety as an FDA-approved drug. The potential uses of quinacrine as an anti-cancer agent are discussed with particular attention to its act...
Main Authors: | Van Waes Carter, Ehsanian Reza, Feller Stephan M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | Cell Communication and Signaling |
Online Access: | http://www.biosignaling.com/content/9/1/13 |
Similar Items
-
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation
by: Nishant S. Kulkarni, et al.
Published: (2020-08-01) -
Pharmacokinetics of quinacrine in the treatment of prion disease
by: Baldwin Michael, et al.
Published: (2004-11-01) -
CHARACTERIZATION OF VR118 QUINACRINE DERIVATIVE AS A POTENTIAL ANTICANCER AGENT
by: Almnayan, Danah
Published: (2014) -
Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites.
by: Jianmin Wang, et al.
Published: (2013-01-01) -
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
by: Victoria P Werth, et al.
Published: (2020-12-01)